Literature DB >> 12160138

Hypersensitivity reactions to carboplatin in children.

Ilaria Lazzareschi1, Antonio Ruggiero, Riccardo Riccardi, Giorgio Attinà, Cesare Colosimo, Anna Lasorella.   

Abstract

Hypersensitivity reactions to carboplatin are rare but sometimes life-threatening events may occur requiring discontinuation of treatment. In our study, we describe clinical features and diagnostic procedures of carboplatin-associated reactions in children affected by low-grade astrocytoma and treated with multiple courses of carboplatin. In 6 out of 29 children, we reported allergic events. We also report a desensitization protocol for carboplatin administration, which allowed the patients to receive effective treatment without adverse reactions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12160138     DOI: 10.1023/a:1015853200090

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  18 in total

1.  Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy.

Authors:  M M Silva; S Goldman; G Keating; M A Marymont; J Kalapurakal; T Tomita
Journal:  Pediatr Neurosurg       Date:  2000-09       Impact factor: 1.162

2.  Hypersensitivity reactions to carboplatin.

Authors:  R S Planner; T Weerasiri; D Timmins; P Grant
Journal:  J Natl Cancer Inst       Date:  1991-12-04       Impact factor: 13.506

3.  [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].

Authors:  A K Gnekow; P Kaatsch; R Kortmann; O D Wiestler
Journal:  Klin Padiatr       Date:  2000 Jul-Aug       Impact factor: 1.349

4.  Carboplatin hypersensitivity: case reports and review of the literature.

Authors:  K S Tonkin; P Rubin; L Levin
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

5.  Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

Authors:  R J Packer; J Ater; J Allen; P Phillips; R Geyer; H S Nicholson; R Jakacki; E Kurczynski; M Needle; J Finlay; G Reaman; J M Boyett
Journal:  J Neurosurg       Date:  1997-05       Impact factor: 5.115

6.  Anaphylaxis to carboplatin following multiple previous uncomplicated courses.

Authors:  A K Sood; M S Gelder; S W Huang; L S Morgan
Journal:  Gynecol Oncol       Date:  1995-04       Impact factor: 5.482

Review 7.  Carboplatin hypersensitivity in children. A report of five patients with brain tumors.

Authors:  S M Chang; S Fryberger; V Crouse; D Tilford; M D Prados
Journal:  Cancer       Date:  1995-03-01       Impact factor: 6.860

8.  Specific IgE antibodies to platinum salts in sensitized workers.

Authors:  O Cromwell; J Pepys; W E Parish; E G Hughes
Journal:  Clin Allergy       Date:  1979-03

Review 9.  Hypersensitivity and cross-reactivity to cisplatin and analogues.

Authors:  A A Shlebak; P I Clark; J A Green
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

10.  Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.

Authors:  C B Broome; R I Schiff; H S Friedman
Journal:  Med Pediatr Oncol       Date:  1996-02
View more
  9 in total

Review 1.  Renal toxicity and chemotherapy in children with cancer.

Authors:  Antonio Ruggiero; Pietro Ferrara; Giorgio Attinà; Daniela Rizzo; Riccardo Riccardi
Journal:  Br J Clin Pharmacol       Date:  2017-09-20       Impact factor: 4.335

2.  Optic pathway gliomas in adolescence--time to challenge treatment choices?

Authors:  Amy Lee Chong; Jason D Pole; Katrin Scheinemann; Juliette Hukin; Uri Tabori; Annie Huang; Eric Bouffet; Ute Bartels
Journal:  Neuro Oncol       Date:  2013-01-07       Impact factor: 12.300

3.  Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma.

Authors:  Dildar Bahar Genc; Cengiz Canpolat; Su Gulsun Berrak
Journal:  Support Care Cancer       Date:  2011-03-17       Impact factor: 3.603

Review 4.  Pediatric low-grade gliomas: how modern biology reshapes the clinical field.

Authors:  Guillaume Bergthold; Pratiti Bandopadhayay; Wenya Linda Bi; Lori Ramkissoon; Charles Stiles; Rosalind A Segal; Rameen Beroukhim; Keith L Ligon; Jacques Grill; Mark W Kieran
Journal:  Biochim Biophys Acta       Date:  2014-02-28

Review 5.  Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer.

Authors:  Antonio Ruggiero; Silvia Triarico; Giovanna Trombatore; Andrea Battista; Fabiola Dell'acqua; Carmelo Rizzari; Riccardo Riccardi
Journal:  Eur J Clin Pharmacol       Date:  2013-06-14       Impact factor: 2.953

Review 6.  Hypersensitivity to Carboplatin in Children with Malignancy.

Authors:  Antonio Ruggiero; Daniela Rizzo; Martina Catalano; Giorgio Attinà; Riccardo Riccardi
Journal:  Front Pharmacol       Date:  2017-04-12       Impact factor: 5.810

7.  Management of Oral Mucositis in Children With Malignant Solid Tumors.

Authors:  Giorgio Attinà; Alberto Romano; Palma Maurizi; Sara D'Amuri; Stefano Mastrangelo; Michele Antonio Capozza; Silvia Triarico; Antonio Ruggiero
Journal:  Front Oncol       Date:  2021-03-30       Impact factor: 6.244

8.  Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions.

Authors:  Antonio Ruggiero; Daniela Rizzo; Martina Catalano; Palma Maurizi; Stefano Mastrangelo; Giorgio Attinà; Riccardo Riccardi
Journal:  Front Pharmacol       Date:  2017-04-07       Impact factor: 5.810

Review 9.  Temozolomide and oral etoposide in children with recurrent malignant brain tumors.

Authors:  Antonio Ruggiero; Anna Ariano; Silvia Triarico; Michele Antonio Capozza; Alberto Romano; Palma Maurizi; Stefano Mastrangelo; Giorgio Attinà
Journal:  Drugs Context       Date:  2020-06-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.